New Achievement of Yeedozencom：Fluoxetine Hydrochloride Capsules of Qianyuan Pharmaceutical have Successfully Passed the Consistency Evaluation of Generic Drugs
Recently, Shanxi Qianyuan Pharmaceutical Group Co., Ltd. received "Drug Supplement Application Approval" of its Fluoxetine Hydrochloride Capsules, which was approved and issued by NMPA. The product has passed the “Consistency evaluation of generic drugs” .
Fluoxetine Hydrochloride Capsules is a kind of drug for nervous system, whose main indications are depression, obsessive-compulsive disorder and bulimia nervosa. The original product was developed by Eli Lilly, and was first put on the market in Belgium in 1986 (trade name: PROZAC).
Being a trial for psychiatric drug, the subject management with very high quality is required in the process. . Yeedozencom, as the partner of Qianyuan Pharmaceutical, was responsible for the organization, implementation and quality assurance of the clinical trial.. With rich experience and rigorous attitude, we successfully helped the product pass the consistency evaluation.
The expert team of Yeedozencom has now carried out BE (bioequivalence) studies of many drugs, including highly variable drugs, special injections and endogenous drugs.
About Qianyuan Pharmaceutical
Shanxi Qianyuan Pharmaceutical Group Co., Ltd. is a pharmaceutical listed enterprise integrating manufacture, R & D and sales. This company concentrates on manufacture and sales of APIs, powder-injections, tablets, hard capsules, granules, powders, suppositories, psychotropic drugs, etc.
About YEEDOZENCOM
Yeedozencom is a professional and market-oriented service provider engaged in the full life-cycle management of drug research and development. Based on the rational cognition and deep expertise on the target products, Yeedozencom devotes itself to proposing the distinctive, proper and thoughtful solutions with warm concerns by experiencing and observing the challenges with Chinese characteristics in the full life cycle (e.g. R&D, manufacture, circulation and use) from the clients’ point of view. After years of accumulation, Yeedozencom has established and optimized the integrated service platform in support of the project operation management, clinical trials, registration services, biospecimen analysis, data management and statistics, aiming to minimize the time costs for pharmaceutical R&D, provide the value-added technical services and early launch the products to the market.
